OCAT | | Ocata Therapeutics, Inc. | Lanza Robert | Chief Scientific Officer | Feb 10, 2016 | Option Exercise | $8.50 | 231,509 | 1,967,827 | 0 | Feb 11, 2016, 04:36 PM |
OCAT | | Ocata Therapeutics, Inc. | Lanza Robert | Chief Scientific Officer | Nov 10, 2015 | Sale | $8.31 | 35,000 | 290,950 | 216,509 | Nov 10, 2015, 04:04 PM |
ACTCD | | ADVANCED CELL TECHNOLOGY, INC. | Lanza Robert | Chief Scientific Officer | Sep 10, 2014 | Sale | $12.53 | 8,930 | 111,900 | 179,439 | Sep 11, 2014, 09:15 AM |
ACTCD | | ADVANCED CELL TECHNOLOGY, INC. | Lanza Robert | Chief Scientific Officer | Sep 08, 2014 | Sale | $10.05 | 15,000 | 150,700 | 194,439 | Sep 09, 2014, 04:09 PM |
ACTCD | | ADVANCED CELL TECHNOLOGY, INC. | Lanza Robert | Chief Scientific Officer | Sep 02, 2014 | Sale | $8.42 | 15,000 | 126,250 | 214,439 | Sep 04, 2014, 04:03 PM |
ACTCD | | ADVANCED CELL TECHNOLOGY, INC. | Lanza Robert | Chief Scientific Officer | Sep 03, 2014 | Sale | $9.00 | 10,000 | 90,000 | 199,439 | Sep 04, 2014, 04:03 PM |
ACTC | | ADVANCED CELL TECHNOLOGY, INC. | Lanza Robert | Chief Scientific Officer | Jul 03, 2014 | Sale | $0.08 | 755,000 | 60,400 | 23,188,822 | Jul 07, 2014, 04:29 PM |
ACTC | | ADVANCED CELL TECHNOLOGY, INC. | Lanza Robert | Chief Scientific Officer | Jul 07, 2014 | Sale | $0.08 | 745,000 | 59,600 | 22,443,822 | Jul 07, 2014, 04:29 PM |
ACTC | | ADVANCED CELL TECHNOLOGY, INC. | Lanza Robert | Chief Scientific Officer | Dec 14, 2012 | Sale | $0.06 | 1,338,490 | 78,617 | 23,937,575 | Feb 05, 2013, 03:58 PM |
ACTC | | ADVANCED CELL TECHNOLOGY, INC. | Lanza Robert | Chief Scientific Officer | Dec 14, 2012 | Sale | $0.06 | 1,338,490 | 78,617 | 27,794,717 | Dec 18, 2012, 06:59 PM |
ACTC | | ADVANCED CELL TECHNOLOGY, INC. | Lanza Robert | Chief Scientific Officer | Jul 30, 2012 | Sale | $0.08 | 1,500,000 | 120,942 | 27,917,296 | Aug 01, 2012, 08:13 AM |
ACTC | | ADVANCED CELL TECHNOLOGY, INC. | Lanza Robert | Chief Scientific Officer | Jul 31, 2012 | Sale | $0.08 | 500,000 | 40,000 | 26,529,003 | Aug 01, 2012, 08:13 AM |
ACTC | | ADVANCED CELL TECHNOLOGY, INC. | Lanza Robert | Chief Scientific Officer | Jan 23, 2012 | Sale | $0.18 | 1,000,000 | 175,400 | 32,615,875 | Jan 25, 2012, 07:17 PM |
ACTC | | ADVANCED CELL TECHNOLOGY, INC. | Lanza Robert | Chief Scientific Officer | Jan 24, 2012 | Sale | $0.19 | 6,658,300 | 1,277,728 | 25,957,575 | Jan 25, 2012, 07:17 PM |
ACTC | | ADVANCED CELL TECHNOLOGY, INC. | Lanza Robert | Chief Scientific Officer | Sep 29, 2011 | Sale | $0.15 | 608,225 | 93,058 | 33,615,875 | Sep 30, 2011, 06:12 PM |
ACTC | | ADVANCED CELL TECHNOLOGY, INC. | Lanza Robert | Chief Scientific Officer | Sep 28, 2011 | Sale | $0.15 | 118,080 | 17,840 | 34,332,180 | Sep 30, 2011, 06:12 PM |
ACTC | | ADVANCED CELL TECHNOLOGY, INC. | Lanza Robert | Chief Scientific Officer | Jun 21, 2011 | Option Exercise | $0.05 | 750,000 | 37,500 | 19,342,180 | Jun 30, 2011, 07:15 PM |
ACTC | | ADVANCED CELL TECHNOLOGY, INC. | Lanza Robert | Chief Scientific Officer | Dec 06, 2010 | Sale | $0.13 | 1,271,864 | 171,320 | 19,220,316 | Dec 08, 2010, 04:00 PM |
ACTC | | ADVANCED CELL TECHNOLOGY, INC. | Lanza Robert | Chief Scientific Officer | Dec 07, 2010 | Sale | $0.15 | 728,136 | 106,745 | 18,492,180 | Dec 08, 2010, 04:00 PM |
ACTC | | ADVANCED CELL TECHNOLOGY, INC. | Lanza Robert | Chief Scientific Officer | Nov 29, 2010 | Sale | $0.08 | 1,000,000 | 83,229 | 24,886,520 | Dec 01, 2010, 04:38 PM |
ACTC | | ADVANCED CELL TECHNOLOGY, INC. | Lanza Robert | Chief Scientific Officer | Nov 30, 2010 | Sale | $0.10 | 3,800,000 | 382,660 | 20,492,180 | Dec 01, 2010, 04:38 PM |
ACTC | | ADVANCED CELL TECHNOLOGY, INC. | Lanza Robert | Chief Scientific Officer | Nov 22, 2010 | Sale | $0.07 | 782,000 | 55,121 | 26,748,180 | Nov 24, 2010, 03:33 PM |
ACTC | | ADVANCED CELL TECHNOLOGY, INC. | Lanza Robert | Chief Scientific Officer | Nov 23, 2010 | Sale | $0.08 | 679,000 | 51,208 | 25,967,430 | Nov 24, 2010, 03:33 PM |
ACTC | | ADVANCED CELL TECHNOLOGY, INC. | Lanza Robert | Chief Scientific Officer | Sep 20, 2010 | Sale | $0.07 | 600,000 | 40,925 | 27,343,180 | Sep 22, 2010, 12:15 PM |
ACTC | | ADVANCED CELL TECHNOLOGY, INC. | Lanza Robert | Chief Scientfic Officer | Aug 20, 2010 | Sale | $0.08 | 600,000 | 45,197 | 27,862,480 | Aug 23, 2010, 05:11 PM |
ACTC | | ADVANCED CELL TECHNOLOGY, INC. | Lanza Robert | Chief Scientific Officer | Jul 20, 2010 | Sale | $0.07 | 497,150 | 35,090 | 28,547,630 | Jul 23, 2010, 12:13 PM |
ACTC | | ADVANCED CELL TECHNOLOGY, INC. | Lanza Robert | Chief Scientific Officer | Jul 21, 2010 | Sale | $0.07 | 102,850 | 7,200 | 27,953,180 | Jul 23, 2010, 12:13 PM |
ACTC | | ADVANCED CELL TECHNOLOGY, INC. | Lanza Robert | Chief Scientific Officer | Jul 20, 2010 | Sale | $0.07 | 1,988,600 | 140,359 | 28,547,630 | Jul 22, 2010, 01:22 PM |
ACTC | | ADVANCED CELL TECHNOLOGY, INC. | Lanza Robert | Chief Scientific Officer | Jul 21, 2010 | Sale | $0.07 | 411,400 | 28,798 | 27,953,180 | Jul 22, 2010, 01:22 PM |